Socioeconomic and Clinical Factors Are Key To Uncovering Disparity in Accrual Onto Therapeutic Trials for Breast Cancer

Restricted access

To monitor and address disparity in accrual, patient participation in cancer clinical trials is routinely summarized by race/ethnicity. To investigate whether confounding obscures racial/ethnic disparity in participation, all women with breast cancer treated by medical oncologists at City of Hope Comprehensive Cancer Center from 2004 through 2009 were classified by birthplace and self-reported race/ethnicity, and followed for accrual onto therapeutic trials through 2010. Undetectable on univariate analysis, significantly reduced participation by subjects of African, Asian, Eastern European, Latin American, and Middle Eastern ancestries was revealed after accounting for age, socioeconomic factors, tumor and oncologist characteristics, and intrapractice clustering of patients.

Correspondence: Carolyn E. Behrendt, PhD, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010. E-mail: cbehrendt@coh.org
  • 1.

    Inclusion of women and minorities as participants in research involving human subjects - policy implementation page. National Institutes of Health Web site. Available at: http://grants.nih.gov/grants/funding/women_min/women_min.htm. Accessed November 30, 2013.

    • Search Google Scholar
    • Export Citation
  • 2.

    Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:27202726.

  • 3.

    Anwuri VV, Hall LE, Mathews K. An institutional strategy to increase minority recruitment to therapeutic trials. Cancer Causes Control 2013;24:17971809.

    • Search Google Scholar
    • Export Citation
  • 4.

    Stewart JH, Bertoni AG, Staten JL. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 2007;14:33283334.

    • Search Google Scholar
    • Export Citation
  • 5.

    Sateren WB, Trimble EL, Abrams J. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:21092117.

    • Search Google Scholar
    • Export Citation
  • 6.

    Ford JG, Howerton MW, Lai GY. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 2008;112:228242.

    • Search Google Scholar
    • Export Citation
  • 7.

    Fayter DA, McDaid C, Eastwood A. A systematic review highlights threats to validity in studies of barriers to cancer trial participation. J Clin Epidemiol 2007;60:9901001.

    • Search Google Scholar
    • Export Citation
  • 8.

    Gross CP, Filardo G, Mayne ST. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 2005;103:483491.

    • Search Google Scholar
    • Export Citation
  • 9.

    Kemeny MM, Peterson BL, Kornblith AB. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003;21:22682275.

    • Search Google Scholar
    • Export Citation
  • 10.

    Simon MS, Du W, Flaherty L. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 2004;22:20462052.

    • Search Google Scholar
    • Export Citation
  • 11.

    Mannel RS, Walker JL, Gould N. Impact of individual physicians on enrollment of patients into clinical trials. Am J Clin Oncol 2003;26:171173.

    • Search Google Scholar
    • Export Citation
  • 12.

    United States Census Bureau. American FactFinder. Available at: http://factfinder2.census.gov. Accessed November 12, 2013.

  • 13.

    Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:6570.

  • 14.

    Unger JM, Hershman DL, Albain KS. Patient income level and cancer clinical trial participation. J Clin Oncol 2013;31:536542.

  • 15.

    Advani AS, Atkeson B, Brown CL. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 2003;97:14991506.

    • Search Google Scholar
    • Export Citation
  • 16.

    Kanarek NF, Tsai HL, Metzger-Gaud S. Geographic proximity and racial disparities in cancer clinical trial participation. J Natl Compr Canc Netw 2010;8:13431351.

    • Search Google Scholar
    • Export Citation
  • 17.

    Davis TC, Williams MV, Marin E. Health literacy and cancer communication. CA Cancer J Clin 2002;52:134149.

  • 18.

    Lara PN Jr, Paterniti DA, Chiechi C. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 2005;23:92829289.

    • Search Google Scholar
    • Export Citation
  • 19.

    Paterniti DA, Chen MS Jr, Chiechi C. Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience. Cancer 2005;104:30153024.

    • Search Google Scholar
    • Export Citation
  • 20.

    Ellis PM, Butow PN, Tattersall MH. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 2001;19:35543561.

    • Search Google Scholar
    • Export Citation
  • 21.

    Liang W, Wang JH, Chen MY. Developing and validating a measure of Chinese cultural views of health and cancer. Health Educ Behav 2008;35:361375.

    • Search Google Scholar
    • Export Citation
  • 22.

    Jenkins V, Farewell V, Farewell D. Drivers and barriers to patient participation in RCTs. Br J Cancer 2013;108:14021407.

  • 23.

    Wright JR, Whelan TJ, Schiff S. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 2004;22:43124316.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 82 62 0
PDF Downloads 16 11 0
EPUB Downloads 0 0 0